U.S. markets closed

Mustang Bio, Inc. (MBIO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.8800+0.2800 (+7.78%)
At close: 4:00PM EDT
Sign in to post a message.
  • b
    bliub
    MBIO has been focusing on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced that the U.S. Food and Drug Administration (“FDA”) has granted Orphan Drug Designation to MB-107, Mustang’s lentiviral gene therapy。 Gene therapy has a huge potential!
    Bullish
  • p
    pierpont
    I heard about MBIO the other day on http://stocktip.xyz. It’s looking like an interesting play.
  • M
    M
    I wonder why all of the comments for the last 7 days were removed?
  • S
    Seth
    WORCESTER, Mass., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on...
    WORCESTER, Mass., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on...
    www.globenewswire.com
  • S
    Seth
    Odd pre-market activity today. Possible news leaking about something?
  • a
    alan
    Looks like the sideways trend is turning up. Looks like next 3 to 5 weeks will be gravy!
    Bullish
  • j
    james
    For all you people buying this MBIO, please do some research. This MBIO hasn't i believe even started testing any of their products in human trials. Mostly mice and petri dishes. Company pumps up stock to certain investors and then does offerings. Be careful.
    Bearish
  • J
    Jon
    Holding 20k at 3.12. Hoping for a pay day after this wild ride.
  • J
    John
    something is definitely afoot. get ready for the derby folks.
  • Y
    Yahoo Finance Insights
    Mustang Bio is up 16.40% to 3.62
  • S
    Savvy Duffer
    Nice move in SONO today. Hopefully news coming soon.
  • J
    JHXS61A
    What is driving the upward trend today?
  • J
    James
    They announced nothing at the Investor meeting. It was a few minutes long and only to have shareholders vote on retaining existing officers. I think the sell off is just short term traders banking on positive news being announced today. Investors should be patient and accumulate at these prices as there are a lot of trial data to be released in the coming weeks/months.
    Bullish
  • C
    Crecy
    Mustang Bio Announces $9.28 Million Grant to Fund Phase 1 Trial of CAR T Therapy MB-103 in HER2-Positive Breast Cancer with Brain Metastases
    City of Hope awarded California Institute for Regenerative Medicine grant to support ongoing Phase 1 clinical trial
    Company Release - 8/13/2019 8:00 AM ET
  • p
    peter
    I've never seen the type of regression of glioblastoma at multiple sites as was achieved with the CAR-T intraventricular injection from City of Hope, that we have licensed. This was published in the New England Journal (NEJM), which speaks to the importance of the result. We are also developing another CAR-T target for glioblastoma. This is the most impressive treatment I have come across for this disease, even though we don't have a series of responses at this time. I think the combination of CAR-Ts and possibly checkpoint blockade with personalized vaccines to prevent escape may revolutionized GBM treatment. This is incredibly exciting and is the primary reason I'm holding this stock.
  • F
    FrankN
    MUSTANG BIO Inc sec form 4 filings insider trading, stock buying and selling.
    MUSTANG BIO Inc sec form 4 filings insider trading, stock buying and selling.
    www.secform4.com
  • r
    rome
    Mustang Bio will use this lentiviral platform for many things, many cures.Modified viruses are so tiny they can go anywhere and do whatever you want .They are the perfect delivery system for gene therapies.
  • A
    Al
    gene therapy is not cheap; it is $850K per case in usa and it is covered by insurance.
  • T
    Tuorah
    Two weeks ago they said they had plenty of money.
    Today public offering.
    Better be 25 plus.